The breast cancer triple negative is the type of cancer more deadly, accounting for half of the deaths attributed to the disease, in which the majority are young women.
This type of cancer is the most aggressive because it has the greatest chance of metastasis, that is, of spreading to other parts of the body besides the part already affected.
Some molecular elements (oncogenes) contaminate good cells and transform them into “bad” cells. The biggest challenge is to fight these cancer cells without harming healthy ones.
And that is exactly what a survey did. The researchers found that clofazimine (antibiotic) can stop the progression of triple breast cancer .
Clofazimine is most effective if used in conjunction with doxorubicin .
While the first drug prevents the reproduction of cancer cells, the second chemical inhibits their growth.
Produced on all continents, this substance is easy to find and is an essential medicine, according to the World Health Organization (WHO).
Until then, this disease did not respond to any type of treatment. With the new discovery, new ways to fight triple negative breast cancer may be developed in the future.
